Roche Seeks Speedy EU Review For Second Bispecific Antibody

Calendar
An accelerated assessment can cut months off the drug review time • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography